BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 37684054)

  • 1. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
    Vincenzi M; Kremić A; Jouve A; Lattanzi R; Miele R; Benharouga M; Alfaidy N; Migrenne-Li S; Kanthasamy AG; Porcionatto M; Ferrara N; Tetko IV; Désaubry L; Nebigil CG
    Pharmacol Rev; 2023 Nov; 75(6):1167-1199. PubMed ID: 37684054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.
    Guilini C; Urayama K; Turkeri G; Dedeoglu DB; Kurose H; Messaddeq N; Nebigil CG
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H844-52. PubMed ID: 20023120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Peptide Agonists and Antagonists of the Prokineticin Receptors.
    Lattanzi R; Miele R
    Curr Issues Mol Biol; 2022 Dec; 44(12):6323-6332. PubMed ID: 36547092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
    Yin TC; Mittal A; Buscaglia P; Li W; Sebag JA
    J Biol Chem; 2023 Jan; 299(1):102814. PubMed ID: 36539034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
    Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
    Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1.
    Maftei D; Vellani V; Artico M; Giacomoni C; Severini C; Lattanzi R
    Neuroscience; 2020 Feb; 427():16-28. PubMed ID: 31883821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin receptors in cardiovascular function: foe or friend?
    Nebigil CG
    Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
    Lattanzi R; Maftei D; Negri L; Fusco I; Miele R
    Neuropeptides; 2018 Oct; 71():32-42. PubMed ID: 30253862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
    Negri L; Lattanzi R
    Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokineticins in angiogenesis and cancer.
    Monnier J; Samson M
    Cancer Lett; 2010 Oct; 296(2):144-9. PubMed ID: 20633984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bv8-prokineticins and their receptors: modulators of pain.
    Negri L; Lattanzi R
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prokineticin system: an interface between neural inflammation and pain.
    Franchi S; Sacerdote P; Panerai A
    Neurol Sci; 2017 May; 38(Suppl 1):27-30. PubMed ID: 28527062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2.
    Matsumoto S; Yamazaki C; Masumoto KH; Nagano M; Naito M; Soga T; Hiyama H; Matsumoto M; Takasaki J; Kamohara M; Matsuo A; Ishii H; Kobori M; Katoh M; Matsushime H; Furuichi K; Shigeyoshi Y
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4140-5. PubMed ID: 16537498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prokineticin 2 in cancer-related inflammation.
    Lattanzi R; Severini C; Miele R
    Cancer Lett; 2022 Oct; 546():215838. PubMed ID: 35921971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1.
    Gasser A; Brogi S; Urayama K; Nishi T; Kurose H; Tafi A; Ribeiro N; Désaubry L; Nebigil CG
    PLoS One; 2015; 10(4):e0121027. PubMed ID: 25831128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals.
    Maftei D; Marconi V; Florenzano F; Giancotti LA; Castelli M; Moretti S; Borsani E; Rodella LF; Balboni G; Luongo L; Maione S; Sacerdote P; Negri L; Lattanzi R
    Br J Pharmacol; 2014 Nov; 171(21):4850-65. PubMed ID: 24902717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokineticin-Receptor Network: Mechanisms of Regulation.
    Lattanzi R; Miele R
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases.
    Nebigil CG
    Front Cardiovasc Med; 2017; 4():20. PubMed ID: 28447033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.